Omicia has raised $23 million from Roche’s ($RHHBY) venture fund and other investors. The Series B round will support the expansion of Omicia’s NGS interpretation and reporting capabilities into new sectors, including clinical trials and life science research.
{iframe}http://www.fiercebiotech.com/it/roche-helps-genomics-software-player-omicia-to-23m-series-b{/iframe}